Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Inv. presentation
Director departure
NovaBay Pharmaceuticals, Inc. (NBY) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/08/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/31/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/31/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/22/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/16/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/15/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/15/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/11/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/16/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/21/2020 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/21/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
06/21/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy